Carregant...
Advances in preclinical approaches to Chagas disease drug discovery
INTRODUCTION: Chagas disease affects 8–10 million people worldwide, mainly in Latin America. The current therapy for Chagas disease is limited to nifurtimox and benznidazole, which are effective in treating only the acute phase of the disease but with severe side effects. Therefore, there is an unme...
Guardat en:
| Publicat a: | Expert Opin Drug Discov |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779130/ https://ncbi.nlm.nih.gov/pubmed/31411084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2019.1652593 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|